Cargando…
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
OBJECTIVE: The main goal of this work was to identify, describe, characterize, and classify the scientific evidence regarding the use of pharmacogenomic biomarkers in antidepressant treatment. METHODS: The work was developed in two phases: i) a search for pharmacogenomic biomarkers in summaries of a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425945/ https://www.ncbi.nlm.nih.gov/pubmed/36042420 http://dx.doi.org/10.1186/s12888-022-04225-2 |